Adrian Berliner leads due diligence at Zoic Capital. He works to develop portfolio intellectual property and conducts research, modeling emerging technologies and characterizing signals of scientific revolution. Adrian has a biotechnology background from the Harvard Chemical Biology Program and consults on development and strategy for biotech startups.